Search

Your search keyword '"Garcia-Aguilar J"' showing total 127 results

Search Constraints

Start Over You searched for: Author "Garcia-Aguilar J" Remove constraint Author: "Garcia-Aguilar J" Topic rectal neoplasms Remove constraint Topic: rectal neoplasms
127 results on '"Garcia-Aguilar J"'

Search Results

1. Deformable Mapping of Rectal Cancer Whole-Mount Histology with Restaging MRI at Voxel Scale: A Feasibility Study.

2. Organ preservation after neoadjuvant long-course chemoradiotherapy versus short-course radiotherapy.

3. Watch and wait in rectal cancer patients with residual mucin on magnetic resonance imaging following neoadjuvant therapy.

4. Chemoradiotherapy plus induction or consolidation chemotherapy as total neoadjuvant therapy for locally advanced rectal cancer: Pooled analysis of the CAO/ARO/AIO-12 and the OPRA randomized phase 2 trials.

5. Assessing Endoscopic Response in Locally Advanced Rectal Cancer Treated with Total Neoadjuvant Therapy: Development and Validation of a Highly Accurate Convolutional Neural Network.

6. MRI Predicts Residual Disease and Outcomes in Watch-and-Wait Patients with Rectal Cancer.

7. Prognostic value of lateral lymph node metastasis in pretreatment MRI for rectal cancer in patients undergoing neoadjuvant chemoradiation followed by surgical resection without lateral lymph node dissection: A systemic review and meta-analysis.

8. Baseline MRI predictors of successful organ preservation in the Organ Preservation in Rectal Adenocarcinoma (OPRA) trial.

9. Alliance A022104/NRG-GI010: The Janus Rectal Cancer Trial: a randomized phase II/III trial testing the efficacy of triplet versus doublet chemotherapy regarding clinical complete response and disease-free survival in patients with locally advanced rectal cancer.

10. Robotic beyond total mesorectal excision for locally advanced rectal cancers: Perioperative and oncological outcomes from a multicentre case series.

11. Future direction of total neoadjuvant therapy for locally advanced rectal cancer.

12. Penile-scrotal erythrodysesthesia among rectal cancer patients receiving fluoropyrimidine-based chemoradiation: a case report series.

13. Anal Adenocarcinoma Treated in the Era of Total Neoadjuvant Therapy and Nonoperative Management.

15. Endoscopic Predictors of Residual Tumor After Total Neoadjuvant Therapy: A Post Hoc Analysis From the Organ Preservation in Rectal Adenocarcinoma Trial.

16. Long-Term Results of Organ Preservation in Patients With Rectal Adenocarcinoma Treated With Total Neoadjuvant Therapy: The Randomized Phase II OPRA Trial.

17. Organ Preservation and Survival by Clinical Response Grade in Patients With Rectal Cancer Treated With Total Neoadjuvant Therapy: A Secondary Analysis of the OPRA Randomized Clinical Trial.

19. Compliance and Toxicity of Total Neoadjuvant Therapy for Rectal Cancer: A Secondary Analysis of the OPRA Trial.

20. NCI Rectal-Anal Task Force consensus recommendations for design of clinical trials in rectal cancer.

21. MRI assessment of rectal cancer response to neoadjuvant therapy: a multireader study.

22. MRI Assessment of Extramural Venous Invasion Before and After Total Neoadjuvant Therapy for Locally Advanced Rectal Cancer and Its Association with Disease-Free and Overall Survival.

23. Deep Learning-Based Model for Identifying Tumors in Endoscopic Images From Patients With Locally Advanced Rectal Cancer Treated With Total Neoadjuvant Therapy.

24. Chemoradiation and Local Excision Versus Total Mesorectal Excision for T2N0 Rectal Cancer: Comparison of Short- and Long-Term Outcomes From 2 Prospective Studies.

25. Assessment of Patient-Reported Outcomes in Patients With Anal Squamous-Cell Cancer Undergoing Combined Modality Therapy.

26. Predictors of operative difficulty in robotic low anterior resection for rectal cancer.

27. A Dynamic Clinical Calculator for Estimating Conditional Recurrence-Free Survival After Total Neoadjuvant Therapy for Rectal Cancer and Either Surgery or Watch-and-Wait Management.

28. Organ Preservation in Patients With Rectal Adenocarcinoma Treated With Total Neoadjuvant Therapy.

29. Genomic and transcriptomic determinants of response to neoadjuvant therapy in rectal cancer.

30. Technical feasibility of salvage endoscopic submucosal dissection after chemoradiation for locally advanced rectal adenocarcinoma.

31. Current controversies in TNM for the radiological staging of rectal cancer and how to deal with them: results of a global online survey and multidisciplinary expert consensus.

32. PD-1 Blockade in Mismatch Repair-Deficient, Locally Advanced Rectal Cancer.

33. Survival After Induction Chemotherapy and Chemoradiation Versus Chemoradiation and Adjuvant Chemotherapy for Locally Advanced Rectal Cancer.

34. The Multimodal Management of Locally Advanced Rectal Cancer: Making Sense of the New Data.

35. MRI at Restaging After Neoadjuvant Therapy for Rectal Cancer Overestimates Circumferential Resection Margin Proximity as Determined by Comparison With Whole-Mount Pathology.

37. Adoption of Organ Preservation and Surgeon Variability for Patients with Rectal Cancer Does Not Correlate with Worse Survival.

38. Identifying Diagnostic MicroRNAs and Investigating Their Biological Implications in Rectal Cancer.

39. Type of recurrence is associated with disease-free survival after salvage surgery for locally recurrent rectal cancer.

40. International consensus recommendations on key outcome measures for organ preservation after (chemo)radiotherapy in patients with rectal cancer.

41. Comparing outcomes of robotic versus open mesorectal excision for rectal cancer.

42. Development and Assessment of a Clinical Calculator for Estimating the Likelihood of Recurrence and Survival Among Patients With Locally Advanced Rectal Cancer Treated With Chemotherapy, Radiotherapy, and Surgery.

43. Prevalence of nodal involvement in rectal cancer after chemoradiotherapy.

44. Neoadjuvant short-course radiotherapy with consolidation chemotherapy for locally advanced rectal cancer: a systematic review and meta-analysis.

45. KRAS mutant rectal cancer cells interact with surrounding fibroblasts to deplete the extracellular matrix.

47. Endoscopic Feature and Response Reproducibility in Tumor Assessment after Neoadjuvant Therapy for Rectal Adenocarcinoma.

48. Rectal cancer with complete endoscopic response after neoadjuvant therapy: what is the meaning of a positive MRI?

49. Rectal cancer lateral lymph nodes: multicentre study of the impact of obturator and internal iliac nodes on oncological outcomes.

Catalog

Books, media, physical & digital resources